Stryker (SYK)
(Delayed Data from NYSE)
$369.56 USD
+9.83 (2.73%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $369.45 -0.11 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$369.56 USD
+9.83 (2.73%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $369.45 -0.11 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Zacks News
Fresh Research Reports For Intel (INTC), AT&T (T) & Others
by Sheraz Mian
Today's must-read reports are for Intel (INTC), Biogen (BIIB) and AT&T (T).
5 Skyrocketing Momentum Stocks
by David Bartosiak
Five red hot momentum stocks breaking out to new highs
MedTech Industry Stock Outlook - Dec. 2015
by Zacks Equity Research
While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.
MedTech Industry Stock Outlook - Dec. 2015
by Zacks Equity Research
While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.
Should You Buy Evolving Trends in Medical Devices?
by Zacks Equity Research
Given the U.S. government's pushback on tax-dodging, we expected some sloth to creep into the medical device space as far as M&As are concerned. But to our surprise, M&A activity worldwide has remained fairly stable.
Momentum Stock Market Game Plan
by David Bartosiak
Momentum Stock Strategist David Bartosiak gives Terry Ruffolo the stock market game plan for today
MedTech Industry Stock Outlook - July/Aug 2015
by Zacks Equity Research
Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.
MedTech Industry Stock Outlook - July/Aug 2015
by Zacks Equity Research
Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.
3 Best Stocks in the Market Today
by David Bartosiak
Stryker and 2 other hard hitting stock buys
MedTech M&As Continue Regardless of Tax Scenarios
by Zacks Equity Research
MedTech stalwarts are not expected to shy away from hostile acquisition bids this year.